Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:reboxetine
|
| gptkbp:approvedBy |
gptkb:Europe
|
| gptkbp:ATCCode |
N06AX18
|
| gptkbp:CASNumber |
98769-81-4
|
| gptkbp:compatibleWith |
gptkb:United_States
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| gptkbp:drugClass |
norepinephrine reuptake inhibitor
|
| gptkbp:hasMolecularFormula |
C19H23NO3
|
| https://www.w3.org/2000/01/rdf-schema#label |
racemic reboxetine
|
| gptkbp:isRacemicMixtureOf |
(R)-reboxetine
(S)-reboxetine |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
constipation
sweating insomnia dry mouth urinary retention |
| gptkbp:synonym |
gptkb:Edronax
|
| gptkbp:usedFor |
treatment of major depressive disorder
|
| gptkbp:bfsParent |
gptkb:reboxetine
|
| gptkbp:bfsLayer |
8
|